48 related articles for article (PubMed ID: 10497785)
21. Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats.
Deng Y; Boomsma F; Yu PH
Life Sci; 1998; 63(23):2049-58. PubMed ID: 9839528
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.
Deng Y; Yu PH
Anal Biochem; 1999 May; 270(1):97-102. PubMed ID: 10328770
[TBL] [Abstract][Full Text] [Related]
23. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
Yu PH; Zuo DM
Diabetologia; 1997 Nov; 40(11):1243-50. PubMed ID: 9389414
[TBL] [Abstract][Full Text] [Related]
24. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications.
Deng Y; Yu PH
J Chromatogr Sci; 1999 Sep; 37(9):317-22. PubMed ID: 10497785
[TBL] [Abstract][Full Text] [Related]
26. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
27. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes.
Yu PH
J Neural Transm Suppl; 1998; 52():201-16. PubMed ID: 9564620
[TBL] [Abstract][Full Text] [Related]
28. [Endogenous formaldehyde and cardiovascular diseases].
Zhang FW; Du JB; Tang CS
Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):17-21. PubMed ID: 21417009
[TBL] [Abstract][Full Text] [Related]
29. Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus.
Ekblom J
Pharmacol Res; 1998 Feb; 37(2):87-92. PubMed ID: 9572061
[TBL] [Abstract][Full Text] [Related]
30. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
Yu PH; Davis BA; Boulton AA; Zuo DM
J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
[TBL] [Abstract][Full Text] [Related]
31. Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?
Lyles GA
J Neural Transm Suppl; 1994; 41():387-96. PubMed ID: 7931255
[TBL] [Abstract][Full Text] [Related]
32. Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes.
Callingham BA; Crosbie AE; Rous BA
Prog Brain Res; 1995; 106():305-21. PubMed ID: 8584667
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
34. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.
Lyles GA
Int J Biochem Cell Biol; 1996 Mar; 28(3):259-74. PubMed ID: 8920635
[TBL] [Abstract][Full Text] [Related]
35. Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase.
Lyles GA
Prog Brain Res; 1995; 106():293-303. PubMed ID: 8584666
[TBL] [Abstract][Full Text] [Related]
36. Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do.
O'Sullivan J; Unzeta M; Healy J; O'Sullivan MI; Davey G; Tipton KF
Neurotoxicology; 2004 Jan; 25(1-2):303-15. PubMed ID: 14697905
[TBL] [Abstract][Full Text] [Related]
37. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
38. Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice.
Göktürk C; Garpenstrand H; Nilsson J; Nordquist J; Oreland L; Forsberg-Nilsson K
Biochim Biophys Acta; 2003 Apr; 1647(1-2):88-91. PubMed ID: 12686114
[TBL] [Abstract][Full Text] [Related]
39. Semicarbazide-sensitive amine oxidase: current status and perspectives.
Mátyus P; Dajka-Halász B; Földi A; Haider N; Barlocco D; Magyar K
Curr Med Chem; 2004 May; 11(10):1285-98. PubMed ID: 15134520
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
